More than a hundred lawsuits waged against Johnson & Johnson’s Janssen Pharmaceuticals alleging the company’s type 2 diabetes drug Invokana caused kidney injuries will stay in federal court after they were removed from state court, a Pennsylvania federal judge ruled. Attorneys representing the 106 plaintiffs had sought to consolidate the cases in Philadelphia Court of Common Pleas, but Janssen removed the cases to federal court under the Class Action Fairness Act. Janssen had asked that the cases ultimately be transferred to New Jersey, where several other Invokana lawsuits are pending. Invokana, known chemically as canagliflozin, was approved by the Food ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.